News

A nonprofit organization is helping turn the tide on readmissions in North Carolina. The small steps it’s taking are resulting in big differences.

Gwen Nichols, MD, chief medical officer of the Leukemia & Lymphoma Society, offers a quick overview of current developments as well as a look forward.

Many healthcare organizations are expanding leadership roles to help meet business and patient-centered goals.

Access to medical records is key to building patient engagement. Here’s why some patients are struggling to access their own data.

The impact of diabetes can have a great impact on everyday life, according to a new survey. Here are some of the biggest effects, and how healthcare executives can help.

What does team-based cancer care done right look like? Here are two real-word models worth emulating.

These tools will reduce healthcare costs and improve care quality.

In previous studies, diabetes has been linked to cognitive impairment and an increased risk for dementia, but a new study sheds light on why that is happening.

Here are 13 things healthcare executives must ask before making a technology investment, according to experts.

State policy variations related to these plans could have significant impacts on the overall insurance market. Here’s what you need to know.

When insurers stopped receiving cost-sharing reduction payments from the government last year, many significantly upped premiums for certain health plans. Here’s more on why they did it, what they did, and six things healthcare executives should know.

FDA approved a novel device to treat breathing difficulty associated with severe emphysema.

A combination melanoma treatment that was just approved by FDA is available through select specialty pharmacies.

As demands on healthcare organizations rise with the transition to value-based care, healthcare executives are being paid differently.

A new study investigates whether PET scans can help guide treatment in patients with aggressive non-Hodgkin lymphomas.

As a healthcare executive you may not conduct research or administer medications, but you can still play an important role in helping improve treatment for lymphoma as well as other blood cancers.  Here are five areas in which you can make an impact.

If you’re not asking the right questions, your healthcare organization could be missing out. Here are five questions every healthcare organization should be asking.

A lymphoma expert from the Allegheny Health Network Cancer Institute reveals the status of current and pipeline lymphoma treatments and the three new treatments healthcare executives need to keep on their radar.

Recommendations focus on ways to prevent opioid misuse and reduce risk of addiction.

How one public trust healthcare system overhauled its overall compensation program and successfully transformed its financial operations.

Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.

A first-of-its kind study examined the association between using medication to treat OUD and mortality in patients who had a nonfatal opioid overdose.

Have two minutes? Listen to this quick podcast for critical takeaways from three of our top articles.

New Cardinal Health Specialty Solutions research shares inside information about oncologists’ views about targeted therapies.

FDA’s approval of a cannabidiol (CBD) medicine to treat seizures associated with 2 severe forms of epilepsy is a positive sign for other CBD drugs under development.